Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) has a beta value of -0.09 and has seen 4.48 million shares traded in the last trading session. The company,
During the recent session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares were 0.93 million, with the beta value of the company hitting -0.09. At the
In the last trading session, 9.65 million shares of the Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) were traded, and its beta was -0.06. Most recently the
In the last trading session, 21.8 million shares of the Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) were traded, and its beta was -0.03. Most recently the
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares stood at 1.7 million during the last session, with the company’s beta value hitting -0.02. At the close
During the recent session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares were 0.44 million, with the beta value of the company hitting -0.03. The 52-week
In the last trading session, 3.98 million Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) shares changed hands as the company’s beta touched -0.08. With the company’s per
In the last trading session, 1.43 million Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) shares changed hands as the company’s beta touched -0.10. With the company’s per
During the last session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares were 0.8 million, with the beta value of the company hitting -0.05. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
